CVS — CVS Health Corporation stock price and chart

CVS

CVS Health CorporationStock · HealthcareS&P 500 Equal Weight 0.2% · S&P 500 0.2% · Russell 1000 0.2% · Russell 3000 0.2% · US Stock Market 0.2% · MSCI World 0.1% · MSCI ACWI 0.1%

$94.66-0.66%

as of market close, Sep 11, 2026

☾ AH — —

PeersMRNALLYUNHJNJMRKABBV

Technical analysis2

Overlay lines0

Addendum charts0

VolumeDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDD

20162019202120242026

50.060.070.080.090.0100.00100.0M$94.66

2026-09-11

Price$94.66

MA20$93.18

MA50$82.13

Vol27.8M

What would $1,000 invested in CVS be worth today? →

CVS returns: By year · By month · By week · Trailing

Key stats

Price data

Price: $94.66
Change YTD: +22.07%
Next earnings: Nov 4, 2026
Market cap: 121.1B2016-09 94.9B2026-09 121.1B+27.6% over the window
Enterprise value: 185.4B
Shares outstanding: 1.3B2016-06 1.1B2026-06 1.3B+20.0% over the window
52W low: $69.51
52W high: $110.68
From 52W high: -14.47%
From 52W low: +36.18%
52W range: 61%
Beta: 0.60

Volume

Rel volume: 0.62×
30D volume: 7.1M
30D $ vol: 684.9M

Fundamentals

Sales (ttm): 415.1B2016-06 166.7B2026-06 415.1B+149.0% over the window
Sales/share: $324.552016-06 $156.372026-06 $324.55+107.5% over the window
EPS (ttm): $3.822016-06 $4.352026-06 $3.82-12.2% over the window
FCF (ttm): 11.8B2016-06 7.1B2026-06 11.8B+66.1% over the window
FCF/share: $9.192016-06 $6.642026-06 $9.19+38.5% over the window
Book value/share: $62.322016-06 $32.602026-06 $62.32+91.1% over the window
Net margin: 1.18%2016-06 2.9%2026-06 1.2%-59.2% over the window
ROE: 6.14%2016-06 13.8%2026-06 6.1%-55.7% over the window
ROA: 1.93%2016-06 5.2%2026-06 1.9%-62.9% over the window
Debt / equity: 0.75×2016-12 0.702026-06 0.75+7.3% over the window
Current ratio: 0.872016-06 1.112026-06 0.87-21.9% over the window

Growth (CAGR, ttm) · 10Y

Sales: +7.36%2025-06-30 → 2026-06-30386.6B → 415.1B (+7.4% total)+6.96%2023-06-30 → 2026-06-30339.2B → 415.1B (+22.4% total)+8.32%2021-06-30 → 2026-06-30278.3B → 415.1B (+49.1% total)+9.55%2016-06-30 → 2026-06-30166.7B → 415.1B (+149.0% total)
Net income: +7.93%2025-06-30 → 2026-06-304.5B → 4.9B (+7.9% total)+18.14%2023-06-30 → 2026-06-303B → 4.9B (+64.9% total)-7.45%2021-06-30 → 2026-06-307.2B → 4.9B (-32.1% total)+0.16%2016-06-30 → 2026-06-304.8B → 4.9B (+1.6% total)
FCF: +146.13%2025-06-30 → 2026-06-304.8B → 11.8B (+146.0% total)-12.70%2023-06-30 → 2026-06-3017.7B → 11.8B (-33.5% total)+0.24%2021-06-30 → 2026-06-3011.6B → 11.8B (+1.2% total)+5.21%2016-06-30 → 2026-06-307.1B → 11.8B (+66.1% total)
Shares: +0.84%2025-06-30 → 2026-06-301.3B → 1.3B (+0.8% total)-0.14%2023-06-30 → 2026-06-301.3B → 1.3B (-0.4% total)-0.62%2021-06-30 → 2026-06-301.3B → 1.3B (-3.1% total)+1.84%2016-06-30 → 2026-06-301.1B → 1.3B (+20.0% total)

Per-share growth (CAGR, ttm) · 10Y

EPS: +6.54%2025-06-30 → 2026-06-30$3.59 → $3.82 (+6.5% total)+18.85%2023-06-30 → 2026-06-30$2.28 → $3.82 (+67.9% total)-6.89%2021-06-30 → 2026-06-30$5.46 → $3.82 (-30.0% total)-1.29%2016-06-30 → 2026-06-30$4.35 → $3.82 (-12.2% total)
Sales/share: +6.47%2025-06-30 → 2026-06-30$304.84 → $324.55 (+6.5% total)+7.11%2023-06-30 → 2026-06-30$264.10 → $324.55 (+22.9% total)+9.00%2021-06-30 → 2026-06-30$210.92 → $324.55 (+53.9% total)+7.58%2016-06-30 → 2026-06-30$156.37 → $324.55 (+107.5% total)
FCF/share: +144.09%2025-06-30 → 2026-06-30$3.77 → $9.19 (+143.9% total)-12.58%2023-06-30 → 2026-06-30$13.76 → $9.19 (-33.2% total)+0.87%2021-06-30 → 2026-06-30$8.80 → $9.19 (+4.4% total)+3.31%2016-06-30 → 2026-06-30$6.64 → $9.19 (+38.5% total)
Book value/share: +2.15%2025-06-30 → 2026-06-30$61.01 → $62.32 (+2.1% total)+3.25%2023-06-30 → 2026-06-30$56.62 → $62.32 (+10.1% total)+2.34%2021-06-30 → 2026-06-30$55.51 → $62.32 (+12.3% total)+6.69%2016-06-30 → 2026-06-30$32.60 → $62.32 (+91.1% total)
Dividend/share: +0.00%2025-06-30 → 2026-06-30$2.66 → $2.66 (+0.0% total)+4.81%2023-06-30 → 2026-06-30$2.31 → $2.66 (+15.2% total)+5.87%2021-06-30 → 2026-06-30$2.00 → $2.66 (+33.0% total)+5.55%2016-06-30 → 2026-06-30$1.55 → $2.66 (+71.6% total)
Price: +26.79%2025-09-11 → 2026-09-11$74.67 → $94.66 (+26.8% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+11.25%2023-09-11 → 2026-09-11$68.75 → $94.66 (+37.7% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+2.47%2021-09-10 → 2026-09-11$83.79 → $94.66 (+13.0% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+0.34%2016-09-09 → 2026-09-11$91.52 → $94.66 (+3.4% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: +30.82%2025-09-11 → 2026-09-11$72.37 → $94.66 (+30.8% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+15.57%2023-09-11 → 2026-09-11$61.31 → $94.66 (+54.4% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+5.92%2021-09-10 → 2026-09-11$70.98 → $94.66 (+33.4% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+3.48%2016-09-09 → 2026-09-11$67.21 → $94.66 (+40.8% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 24.8×2016-09 18.582026-09 24.76+33.3% over the window
P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.: 14.6×2016-09 9.402026-09 14.61+55.4% over the window
Fwd P/E: 11.3×
P/S (ttm)Market cap ÷ TTM revenue.: 0.3×2016-09 0.552026-09 0.29-46.9% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 1.5×2016-09 2.642026-09 1.52-42.5% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 10.3×2016-09 10.282026-09 10.30+0.2% over the window
EV/EBITDA (fy): 14.5×
EV/Sales (ttm): 0.4×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 9.71%2016-06 7.5%2026-06 8.8%+18.3% over the window
Dividend yield (fwd)Indicated forward annual dividend ÷ current price — the rate the company has announced, not what was actually paid over the past year.: 2.81%
Dividend/share (fwd): $2.66
Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 1.28B ÷ 1.27B. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: -0.84%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-0.84%) + dividends paid over that year ($3.4B) ÷ market_cap_at(2025-06-30) ($87.5B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: 3.06%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($0) ÷ today's market cap ($121.1B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 0.00%2016-06 6.4%2026-06 0.0%-100.0% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $0 + TTM dividends $3.4B) ÷ today's market cap ($121.1B). Same caveat as the cash buyback yield.: 2.82%2016-06 8.2%2026-06 2.6%-68.6% over the window

Vs own 10Y history

P/E: 81st
P/OI: 83rd
P/S: 33rd
P/B: 57th
P/FCF: 62nd

Bar = where today’s multiple sits in CVS’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · windows as of 2026-09-11

-0.66%

-2.61%

-0.06%

-5.21%

YTD

+22.07%

+32.03%

+28.49%

Financial statements

Open full CVS financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	-8.44%	-0.65%
JNJ	Johnson & Johnson	+2.31%	-0.29%
ABBV	AbbVie Inc.	+3.36%	+0.83%
MRK	Merck & Co. Inc.	+8.28%	-0.54%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	-6.53%	-2.37%
TMO	Thermo Fisher Scientific Inc.	+1.13%	+1.10%
AMGN	Amgen Inc.	-8.80%	-1.34%
GILD	Gilead Sciences Inc.	+5.78%	-0.75%

CVS Health Corporation (CVS) trades at $94.66 with a live price and an interactive chart covering 53+ years of daily price history, plus key valuation metrics. ChartRow also publishes CVS’s financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full CVS financial statements →

CVS — CVS Health Corporation price, chart and key statistics